Literature DB >> 16311408

Recent progress in studies of pituitary tumor pathogenesis.

Takeo Minematsu1, Shunsuke Miyai, Hanako Kajiya, Masanori Suzuki, Naoko Sanno, Susumu Takekoshi, Akira Teramoto, Robert Y Osamura.   

Abstract

The mechanisms of tumorigenesis of the human pituitary have been elucidated to a limited extent. Classically, pituitary tumor formation was shown to be induced by thyroidectomy and estrogen administration. Molecular biological and immunohistochemical studies have revealed several aspects of pituitary tumorigenesis. Translineage cell differentiation has been shown to be induced by the aberrant expression of transcription factors and co-factors, such as Pit-1, Prop-1, and estrogen receptor. Defects or overexpression of cell cycle regulators, such as CDK inhibitors, PTTG, and GADD45gamma, result in the abnormal proliferation of pituitary cells. Recently, epigenetic regulation has been suggested to be related to pituitary tumor formation. This article presents a review and update of recent progress in studies of the development and differentiation of pituitary tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311408     DOI: 10.1385/ENDO:28:1:037

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

1.  The pituitary-specific transcription factor, Pit-1, can direct changes in the chromatin structure of the prolactin promoter.

Authors:  Paul Kievit; Richard A Maurer
Journal:  Mol Endocrinol       Date:  2004-09-16

2.  The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein.

Authors:  M Bodner; J L Castrillo; L E Theill; T Deerinck; M Ellisman; M Karin
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

3.  Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone.

Authors:  S L Asa; K Kovacs; L Stefaneanu; E Horvath; N Billestrup; C Gonzalez-Manchon; W Vale
Journal:  Proc Soc Exp Biol Med       Date:  1990-03

4.  Expression of GATA-2 in human pituitary adenomas.

Authors:  Katsuya Umeoka; Naoko Sanno; R Yoshiyuki Osamura; Akira Teramoto
Journal:  Mod Pathol       Date:  2002-01       Impact factor: 7.842

5.  Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.

Authors:  H Zou; T J McGarry; T Bernal; M W Kirschner
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

6.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

7.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.

Authors:  Helai P Mohammad; Rula A Abbud; Al F Parlow; Jonathan S Lewin; John H Nilson
Journal:  Endocrinology       Date:  2003-07-17       Impact factor: 4.736

9.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene.

Authors:  K E Mayo; R E Hammer; L W Swanson; R L Brinster; M G Rosenfeld; R M Evans
Journal:  Mol Endocrinol       Date:  1988-07

10.  Immunohistochemical expression of PIT-1 protein in pituitary glands of human GRF transgenic mice: its relationship with hormonal expressions.

Authors:  R Y Osamura; K Oda; H Utsunomiya; K Inada; S Umemura; M Shibuya; H Katakami; J W Voss; K E Mayo; M G Rosenfeld
Journal:  Endocr J       Date:  1993-02       Impact factor: 2.349

View more
  6 in total

1.  PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.

Authors:  Takeo Minematsu; Masanori Suzuki; Naoko Sanno; Susumu Takekoshi; Akira Teramoto; R Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

2.  Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Fatma Ela Keskin; Buge Oz; Ozlem Asmaz Haliloglu; Necmettin Tanriover; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

3.  PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines.

Authors:  Takeo Minematsu; Noboru Egashira; Hanako Kajiya; Mao Takei; Susumu Takekoshi; Yoshiko Itoh; Hideo Tsukamoto; Johbu Itoh; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

4.  Novel Pituitary Actions of Epidermal Growth Factor: Receptor Specificity and Signal Transduction for UTS1, EGR1, and MMP13 Regulation by EGF.

Authors:  Qiongyao Hu; Shaohua Xu; Cheng Ye; Jingyi Jia; Lingling Zhou; Guangfu Hu
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

5.  Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.

Authors:  Ryosuke Mori; Naoko Inoshita; Junko Takahashi-Fujigasaki; Tatsuhiro Joki; Hiroshi Nishioka; Toshiaki Abe; Takeshi Fujii; Shozo Yamada
Journal:  ISRN Endocrinol       Date:  2013-01-21

Review 6.  Pathology of the human pituitary adenomas.

Authors:  Robert Y Osamura; Hanako Kajiya; Mao Takei; Noboru Egashira; Maya Tobita; Susumu Takekoshi; Akira Teramoto
Journal:  Histochem Cell Biol       Date:  2008-08-08       Impact factor: 4.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.